HHS watchdog office steps up focus on drug pricing

(By Ed Silverman for STAT)

Seeking to address rising concerns about prescription medicines, the watchdog arm of the US Department of Health Human Services is adding to its list of pharmaceutical issues to be examined. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.